Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002389762 | SCV002700481 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-03-03 | criteria provided, single submitter | clinical testing | The c.104_105dupGC pathogenic mutation, located in coding exon 1 of the MSH2 gene, results from a duplication of GC at nucleotide position 104, causing a translational frameshift with a predicted alternate stop codon (p.L36Afs*29). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |